Healthcare Uncensored
What happens when venture capital stops funding “digital band-aids” and starts investing in technologies that could fundamentally rewrite the future of healthcare? In this episode of Healthcare Uncensored, Rani Khetarpal sits down with Abhi Mukherjee, Partner at CIVC, for a bold conversation about innovation, prevention, quantum computing, and why the healthcare industry can no longer rely on the myth of the “average patient.” Abhi shares his journey from technology leadership and entrepreneurship into venture capital, explaining how his firm is focused on backing companies that don’t just improve broken systems, but eliminate fragmentation entirely. Together, Rani and Abhi unpack the shift from reactive “sick care” to predictive, personalized healthcare powered by AI, quantum technologies, and purpose-driven innovation. From the future of preventative medicine to what investors are really looking for in founders, this conversation challenges conventional thinking around healthcare, funding, and the technologies shaping the next decade. In This Episode: * Why Abhi believes “the average patient” no longer exists * The shift from sick care to predictive, preventative healthcare * How quantum computing could transform medicine and diagnostics * Why healthcare investors are moving beyond “AI-first” companies * The problem with “digital band-aids” in healthcare innovation * How technology should enable outcomes, not drive them * Why purpose matters more than passion when pitching investors * The importance of commercialization and real-world adoption * How healthcare founders can better communicate their “why” * What the future of venture capital in healthcare may look like About the Guest: Abhi Mukherjee is a Partner at CIVC, where he focuses on healthcare innovation, deep tech, AI, and emerging frontier technologies. With more than 25 years of experience in technology leadership, innovation strategy, and venture capital, Abhi is known for identifying transformative technologies that bridge the gap between breakthrough science and real-world healthcare impact. Abhi was a founding member of the UST Corporate Venture Capital (CVC) team and previously founded the Enterprise AI startup, Nirveda Cognition, leading it to a successful acquisition in 2021. Abhi serves as an Advisor to the Harvard Business Review Advisory Council, as well as the Strategic Leadership Council for New Mexico LEEP which facilitates strategic commercialization partnerships between Los Alamos and Sandia National Laboratories. Listen to more episodes on Mission Matters: https://missionmatters.com/author/rani-khetarpal/ [https://missionmatters.com/author/rani-khetarpal/]
9 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Healthcare Uncensored!